Reynaers Ireland win Reynaers global CSR Awards with their Implementation of RediCare Control
Jun 2020 –
‘The Jurys Verdict
The initiative of Reynaers Ireland received the maximum score from all members of the jury. The engagement of the whole team, the long duration of the project and the use of a digital tool convinced them of its merit. The digital tool ensured commitment to the project and allowed for constant monitoring.’
Helen Meade, Communications & Marketing Manager at Reynaers Ireland who introduced the programme commented.
I’ve been with Reynaers for 15 years now and this is by far the best initiative I’ve ever experienced here.’
About RediCare
RediCare is a digital therapeutics firm. With our core product RediCare ControlDTx patients are transforming their health across the spectrum of metabolic health. They are experiencing clinically significant reductions in Weight, HbA1c, Blood Pressure and improved Lipid profiles and PCOS remission. Many Type 2 Diabetic patients have reduced and eliminated their diabetes medications.
RediCare ControlDTx is creating a new normal in prescription digital therapeutics for treating cardiometabolic diseases. We envision a new way to treat diseases like Type 2 diabetes and heart disease by targeting the root cause, not just the effects, using prescription digital therapeutics to deliver personalized clinically validated lifestyle therapy.
RediCare partners with primary care practices in the UK and Ireland and serves over 140 corporate clients with chronic disease screening and management services.